SAN DIEGO, Jan. 19, 2011 /PRNewswire/ — Santarus, Inc.
(Nasdaq: SNTS) announces that a live audio webcast and
accompanying slide presentation will be provided for its Analyst
Day and Investor Briefing.  

Details of the event are as follows:What:Santarus Analyst Day
and Investor BriefingWhen:Today, Wednesday, January 19, 2011 at
4:15 p.m. Eastern timeWhere:www.santarus.com (under
the Investor Relations link)AGENDA

Strategic Overview and 2011 Financial Outlook

Gerald T. Proehl, President, Chief Executive Officer &
Director, Santarus, Inc.

CYCLOSET® – Clinical/Medical Background

Dr. J. Michael Gaziano, Chief, Division of Aging, Brigham &
Women’s Hospital,

Professor of Medicine, Harvard Medical School

ULTESA™ (Budesonide MMX®) – Overview and Top-line
Phase III Clinical Study Results

Dr. Simon P.L. Travis, Consultant Gastroenterologist,

Translational Gastroenterology Unit, John Radcliffe Hospital,
Oxford, UK

Ulcerative Colitis – Treatment Perspective

Dr. William J. Sandborn, Professor of Clinical Medicine and Chief
of the Division of Gastroenterology,

University of California, San Diego

RHUCIN® and Hereditary Angioedema (HAE)

Dr. Bruce L. Zuraw, Professor of Medicine and Chief, Allergy and
Immunology, University of California, San Diego,

Research Scientist, San Diego VA Healthcare

SAN-300 (anti-VLA-1 antibody)

Dr. Mark C. Totoritis, Senior Vice President, Biologics, Santarus,
Inc.

Wrap-up/Question & Answer Session

Gerald T. Proehl, President, Chief Executive Officer &
Director, Santarus, Inc.

How:Live over the Internet – Simply log on t

‘/>”/>

SOURCE